Osteoporosis or porous bone is a disease characterized by a low bone density and a structural deterioration of the bone tissue, leading to a bone fragility that increases susceptibility to hip and spine fractures. This study evaluates the association among coffee, alcohol, smoking, chronic use of corticoids, menarchial age, years after the menopause and use of hormonal replacement therapy with the appearance of osteoporosis in postmenopausal women whose clinical files are found in the Physical Medicine and Rehabilitation Department at the Complejo Metropolitano Dr. Arnulfo Arias Madrid from january 2002 through april 2004 (122 cases and 122 controls, all postmenopausal women). This is a study in unmatched cases and controls by which the gathering of data was carried out by means of a close survey of an interview type via telephone. We found out the following variables: OR=2,4 for coffee ingesta and OR=3,5 for alcohol ingesta; both variable were statistically significant. In addition, we found out that the early menarchial variable as well as the hormonal replacement therapy variable are protective factores with an OR=0,3 and 0,4 respectively. On the other hand, we couldn't establish statistical significance in the smoking and use of chronic corticoids variables.
Downloads
Download data is not yet available.
References
Orozco P. Actualización en el abordaje y tratamiento de la Osteoporosis. Inf Ter Sist Nac Salud 2001;25:117-41.
Robertson P. Osteoporosis: epidemiology, diagnosis, and treatment. South Med J 2000;93:2-18.
Robertson P. Treatment of Osteoporosis with bisphosphonates. Rheum Dis Clin North Am 2001;27:197-214.
National Osteoporosis Foundation. Osteoporosis clinical practice guideline: Physician's guide to prevention and treatment of osteoporosis. Washington, DC; 1998.
Bauer D, Browner WS, Carley JA, Orwoll ES, Scott JC, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med 1993;118:657-65.
Kiel DP, Zhang Y, Hannan MT, Anderson JJ, Baron JA, Felson DT. The effect of smoking at different life stages on bone mineral density in elderly men and women. Framingham Study Group. Osteoporosis Int 1996;6(3):240-8.
Harris SS. Effects of caffeine consumption on hip fracture, bone density, and calcium retention. Nutritional Aspects of Osteoporosis. New York: Springer Verlag, 1998.
Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density, and risk of hip fracture: recognition of a major effect. Br Med J 1997;315:841-6.
Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
Kaufman JM. Role of calcium and vitamin D in the prevention and treatment of postmenopausal osteoporosis: an overview. J Clin Rhe 1995;14:9.
O'Neill TW, Silman AJ, Naves Diaz MN, Cooper C, Kanis J, Felsenberg D. The European Vertebral Osteoporosis Study. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporosis Int 1997;7:72-8.
New SA, Bolton-Smith C, Grubb DA, Reid DM, et al. Nutritional influences on bone mineral density: A cross-sectional study in premenopausal women. Am J Clin Nutr 1997;65:1831-9.
Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:429-541.
Kuohung W, Borgatta L, Stubblefield P. Low dose oral contraceptives and bone mineral density: An evidence-based analysis. Contraception 2000;61:77-82.
Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
Cumming SR, Nevitt MC, Browner WS, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332(12):767-73.
Heaney RP. Calcium, dairy products, and osteoporosis. J Am Coll Nutr 2000;19:83-99.
Silman AJ, O'Neill TW, Cooper C, Kanis J, Felsenberg D. Influence of physical activity on vertebral deformity in men and women: results from The European Vertebral Osteoporosis Study. J Bone Miner Res 1997;12:813-9.
Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
MacLennan W. Osteoporosis. Br Med Bull 1990;46:94-112.
